The UK’s largest medical cannabis company has announced a new capital raise and the completion of an internal restructure. This new raise will support Lyphe Group to become cash flow…
/vɒlt'fæs/
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept